<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04809454</url>
  </required_header>
  <id_info>
    <org_study_id>1241985</org_study_id>
    <nct_id>NCT04809454</nct_id>
  </id_info>
  <brief_title>Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt</brief_title>
  <acronym>I2 and thyroid</acronym>
  <official_title>Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt: A Cross Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Services Institute of Medical Sciences, Pakistan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Services Institute of Medical Sciences, Pakistan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroxin a vital hormone for life lot of body functions depend on proper functioning on&#xD;
      pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them&#xD;
      containing two iodine atoms on their inner (tyrosine) ring. Synthesis of reasonable&#xD;
      quantities of thyroid hormones requires adequate iodine intake to allow sufficient thyroidal&#xD;
      uptake. The World Health Organization (WHO) recommendation for daily intake of iodine is 150&#xD;
      μg for children ≥12 years and adults, and 250 μg for pregnant and lactating women. However as&#xD;
      we know optimum amount of iodine is required for normal pituitary thyroid axis like wise&#xD;
      excessive intake may cause over functioning of axis hence over production of hormone that can&#xD;
      be manifested both clinically and biochemically.&#xD;
&#xD;
      This study is designed to observe the frequency of over hyperthyroidism in patients taking&#xD;
      iodinated salt.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients presenting to endocrine clinic fulfilling inclusion and exclusion criteria will&#xD;
      be recruited. They will be examined, their vitals including blood pressure pulse will be&#xD;
      noted, thyroid clinical examination including eye signs and thyroid status will be done&#xD;
      biochemical Thyroid profile (TSH, Free T3 &amp; Free T4) will be noted in predesigned proforma.&#xD;
&#xD;
      Statistical Analysis will be done ,after data is entered in Statistical Package for the&#xD;
      Social Sciences (SPSS) version 25 .qualitative data will be presented as frequencies and&#xD;
      percentages while quantitative data will be presented as mean medians and standard&#xD;
      deviations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Affect of Iodinated Salt on Thyroid Status</measure>
    <time_frame>through study completion an average of 12 weeks</time_frame>
    <description>Affect of Iodinated Salt on Thyroid Status</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Thyroid Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients presenting with biochemical hyperthythyroidism and taking Iodinated salt with&#xD;
        age range of 18-60 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. All patients presenting with biochemical hyperthyroidism&#xD;
&#xD;
          2. Who are taking Iodinated salt.&#xD;
&#xD;
          3. Treatment naïve patients&#xD;
&#xD;
          4. Both genders included&#xD;
&#xD;
          5. All patients who can give consent (18-60 years)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1) Pregnant females 2) Lactating mothers&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mehwish Iftikhar, FCPS Endocrinologyy</last_name>
    <phone>923004291641</phone>
    <email>drmehwish19@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amna Rizvi, FCPS Endocrinology</last_name>
    <phone>923009463345</phone>
    <email>amnarizvi512@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mehwish Iftikhar</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <contact>
      <last_name>Mehwish Iftikhar, FCPS Endocrinology</last_name>
      <phone>923004291641</phone>
      <email>drmehwish19@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Amna Rizvi, FCPS Endocrinology</last_name>
      <phone>923009463345</phone>
      <email>amnarizvi512@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Services Institute of Medical Sciences, Pakistan</investigator_affiliation>
    <investigator_full_name>Mehwish Iftikhar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Thyroid</keyword>
  <keyword>Iodine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperthyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

